Johan Sjodahl
Chief Tech/Sci/R&D Officer chez ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Profil
Johan Sjodahl is currently the Chief Scientific Officer at ISR Immune System Regulation Holding AB since 2021.
He has a graduate and doctorate degree from the Royal Institute of Technology.
Postes actifs de Johan Sjodahl
| Sociétés | Poste | Début |
|---|---|---|
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Formation de Johan Sjodahl
| Royal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
